---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-031164"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2023-08-31T23:59:59+00:00"
generated_at: "2026-06-11T01:42:40.690651+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# BioLife Solutions issues investor presentation; no specific financial updates disclosed

## Summary
- Filed investor presentation dated August 2023 under Item 7.01 Regulation FD.
- Presentation is available on company website; no earnings or operational milestones highlighted.
- No material financial or strategic changes mentioned in the limited exhibit provided.

## SEC filing metadata
- accession: 0001628280-23-031164
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2023-08-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828023031164/0001628280-23-031164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828023031164/blfs-20230830.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-031164
- JSON: https://secwatch.observer/filing/0001628280-23-031164.json
- Plain text: https://secwatch.observer/filing/0001628280-23-031164.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.